NewGenIvf acquires Cytometry Tech to expand U.S. fertility services; shares up

* NewGenIvf Group (NASDAQ:NIVF [https://seekingalpha.com/symbol/NIVF]) has acquired cytometry technology, including 18 fully-built cell-sorting systems, 8 partial units, and 6 microfluidics-related patents.
* The acquisition enhances NewGen's capabilities in sperm sorting and supports its U.S. expansion of NewGenSort services.
* Projected gross revenue from full U.S. operations is estimated to exceed $20M annually.
* Acquired manufacturing know-how is expected to lower costs and enable further cytometer production.
* The initial U.S. rollout of NewGenSort is planned for Q1 2026.
* NewGenSort, formerly MicroSort, uses flow cytometry to separate X and Y chromosome-bearing sperm for IVF.
* The 18 cytometers will be deployed in the U.S., targeting a growing fertility market with over 432,000 IVF cycles in 2023.
* Each machine can perform up to 4 sorts daily, enabling over 25,000 sorts annually, under 6% of total U.S. IVF cycles.
* NIVF shares up 21.7% premarket on Tuesday.
* Source: Press release [https://seekingalpha.com/pr/20181075-newgen-announces-strategic-acquisition-of-cytometry-technology-and-assets-to-support-planned]

MORE ON NEWGENIVF

* NewGen announces $45 million strategic investment in UAE real estate market [https://seekingalpha.com/news/4457584-newgen-announces-45-million-strategic-investment-in-uae-real-estate-market]
* Financial information for NewGenIvf [https://seekingalpha.com/symbol/NIVF/income-statement]